If you learn one new fact today, it should be that 100,000 people worldwide die each year because of counterfeit drugs. This staggering statistic makes it all the more obvious why we need global solutions to counterfeit drug trafficking.
Bill Reid, our senior director of Global Anti-Counterfeiting Operations, recently contributed an insightful blog to Pharmaphorum on the varying costs of counterfeit drugs. At Lilly, we continue to be vocal proponents of comprehensive solutions to counterfeiting, not only because of the billions of dollars it costs the pharmaceutical industry each year, but also because of the thousands of sick individuals who are cheated out of life-saving treatment.
Encouraging policies like the Falsified Medicines Directive, which creates harmonized pan-European safety measures, and technologies such as serialization is key to saving lives and making it more difficult for counterfeiters to traffic fake meds.
If you’ve ever purchased medication or know someone who relies on medication, this concerns you. Take a moment and read what Bill has to say about the nature of counterfeit drug trafficking, the measures being taken to stop it, and what you can do to take action.